USA FDA approves ANDAs for Plan B One-Step and Trandate
05:17 EDT 16 Jul 2012 | thePharmaLetter
Watson Pharmaceuticals (NYSE: WPI) says its subsidiary Watson Laboratories approval from the US Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for Next Choice ONE DOSE (levonorgestrel Tablet, 1.5 mg), the generic equival..
Original Article: USA FDA approves ANDAs for Plan B One-Step and Trandate
More From BioPortfolio on "USA FDA approves ANDAs for Plan B One-Step and Trandate"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
